Page 1 of Clinical Trials for endometrial papillary serous carcinoma, 29 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer
2
Not yet recruiting
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
Last Updated: May 3, 2011
Condition(s): Endometrial Cancer
3
Recruiting
Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumor
Last Updated: May 2, 2012
Condition(s): Endometrial Cancer; Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Liver Cancer; Lung Cancer; Ovarian Cancer
4
Recruiting
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Last Updated: February 3, 2012
Condition(s): Endometrial Cancer; Fatigue; Neurotoxicity
5
Active, not recruiting
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer
6
Completed
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer
7
Completed
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer
8
Recruiting
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Last Updated: February 3, 2012
Condition(s): Endometrial Cancer
9
Completed
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer
10
Recruiting
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
Last Updated: November 22, 2011
Condition(s): Endometrial Cancer
11
Completed
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
Last Updated: December 20, 2011
Condition(s): Endometrial Cancer; Psychosocial Effects of Cancer and Its Treatment
12
Recruiting
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Last Updated: May 18, 2012
Condition(s): Endometrial Cancer
13
Recruiting
AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
Last Updated: May 18, 2012
Condition(s): Endometrial Cancer
14
Active, not recruiting
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
15
Recruiting
RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors
Last Updated: July 8, 2011
Condition(s): Endometrial Cancer; Kidney Cancer; Unspecified Adult Solid Tumor, Protocol Specific
16
Active, not recruiting
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
Last Updated: April 28, 2011
Condition(s): Endometrial Cancer
17
Not yet recruiting
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Last Updated: September 24, 2011
Condition(s): Endometrial Cancer
18
Completed
Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer
19
Active, not recruiting
Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer
Last Updated: June 21, 2011
Condition(s): Endometrial Cancer
20
Active, not recruiting
Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=endometrial+papillary+serous+carcinoma

Page 1 of Clinical Trials for endometrial papillary serous carcinoma, 29 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About